• 1
    Squiers LB, Holden DJ, Dolina SE, Kim AR, Bann CM, Renaud JM. The public's response to the US Preventive Services Task Force's 2009 recommendations on mammography screening. Am J Prey Med. 2011; 40: 497-504.
  • 2
    US Preventive Services Task Force. Screening for breast cancer: US Preventive Services Task Force recommendation statement. Ann Intern Med. 2009; 151: 716-726; W-236.
  • 3
    Smith RA, Saslow D, Sawyer KA, et al. American Cancer Society guidelines for breast cancer screening: update 2003. CA Cancer J CIin. 2003; 54: 141-169.
  • 4
    Smith RA, Cokkinides V, Brooks D, Saslow D, Shah M, Brawley O. Cancer screening in the United States, 2011: a review to current American Cancer Society guidelines and issues in cancer screening. CA Cancer J Clin. 2011; 61: 8-30.
  • 5
    Gotzsche PC, Nielsen M. Screening for breast cancer with mammography. Cochrane Database Syst Rev. 2011; ( l): C0001877.
  • 6
    Takahashi J, Hardesty L, Jin M, Horn W. Survey to screening mammography ordering practices to primary care physicians before and after the release to the November 2009 United States Preventative Services Task Force screening mammography guidelines. AIR Am J Roentgenol. 2011; 196: A1.
  • 7
    Hendrick RE, Helvie MA. United States Preventive Services Task Force screening mammography recommendations: science ignored. AJR Am J Roentgenol 2011; 196: W112-W116.
  • 8
    Plecha D, Kremer M, Pham R, et al. Neglecting to screen women aged 4049 years with mammography: what is the impact on breast cancer diagnosis. MR Am J Roentgenol. 2011; 196: A2.
  • 9
    Hellquist BN, Dully SW, Abdsaleh S, et al. Effectiveness of population-based service screening with mammography for women ages 40 to 49 years: evaluation to the Swedish Mammography Screening in Young Women (SCRY)cohort. Cancer. 2011; 117: 714-722.
  • 10
    Tabar L, Faberberg C, Day NE, Holmberg L. What is the optimum interval betueen mammographic screening examinations? An analysis based on the late results to the Swedish two-county breast cancer screening trial. Br J Cancer. 1987; 55: 547-551.
  • 11
    Hunt KA, Rosen EL, Sickles RE. Outcome analysis for women undergoing annual versus biennial screening mammography: a review to 24,211 examinations. AJR Am J Roentgenol 1999; 173: 285-289.
  • 12
    Feig S. Comparison to costs and benefits to breast cancer screening with mammography, ultrasonography, and MRI. Obstet Gynecol Clin North Am. 2011; 38: 179-196, ix.
  • 13
    Tengs TO, Adams M, Pliskin J, et al. Five-hundred life-saving interventions and their cost-effectiveness. Risk Anal. 1995; 15: 369-390.
  • 14
    Rosenquist Cl, Lindtors KK. Screening mammography beginning at age 40 years: a reappraisal to cost-effectiveness. Cancer. 1998; 82: 2235-2240.
  • 15
    Gierisch JM, O'Neill SC, Rimer BK, DeFrank JT, Bowling JM, Skinner CS. Factors associated with annual-interval mammography for women in their 40s. Cancer Epidemiol. 2009; 33: 72-78.
  • 16
    Gierisch JM, Earp JA, Brewer NT, Rimer BK. Longitudinal predictors to nonadherence to maintenance to mammography. Cancer Epidemiol Biomarkers Prey. 2010; 19: 1103-1111.
  • 17
    Tabar L, Yen MF, Vitak B, Chen HT, Smith RA, Duffy SW. Mammography service screening and mortality in breast cancer patients: 20-year follow-up before and after introduction to screening. Lancer 2003; 361: 1405-1410.
  • 18
    Tabar L, Duffy SW, Vitak B, Chen HH, Prevost TC. The natural history to breast carcinoma: what have we learned from screening? Cancer. 1999; 86: 449-462.
  • 19
    Calvocoressi L, Sun A, Kasl SV, Claus EB, Jones BA. Mammography screening to women in their 40s: impact to changes in screening guidelines. Cancer. 2008; 112: 413-480.
  • 20
    Jemal A, Siegel R, Xu I, Ward E. Cancer statistics. 2010. CA Cancer J Clin. 2010; 60: 277-300.